IAMOG
CLSD

Investors Asset Management of Georgia’s Clearside Biomedical CLSD Stock Holding History

Investors Asset Management of Georgia’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17
Closed – – 243
2022
Q3 		$0 Hold
17
– – ﹤0.01% 615
2022
Q2 		$0 Buy
+17
New +$413 ﹤0.01% 581

Other funds holding CLSD

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Investors Asset Management of Georgia's CLSD Position: Q4 2022 in Review

Investors Asset Management of Georgia sold out of Clearside Biomedical (CLSD) in Q4 2022, closing a stake of 17 shares.

Investors Asset Management of Georgia first reported a position in CLSD in Q2 2022 and held it in 2 quarters. The position peaked at $0 in Q3 2022. 53 funds tracked by Wall St. Rank hold CLSD as of Q4 2022.

  • Investors Asset Management of Georgia reported no remaining Clearside Biomedical position as of Q4 2022 after selling out during the quarter.
  • Investors Asset Management of Georgia sold 17 Clearside Biomedical shares in Q4 2022.
  • Investors Asset Management of Georgia first reported a position in Clearside Biomedical in Q2 2022 and held it in 2 quarters.
  • Investors Asset Management of Georgia's Clearside Biomedical position peaked at $0 in Q3 2022.
  • 53 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2022.

Based on Investors Asset Management of Georgia's 13F filing for Q4 2022, filed 2 Feb 2023.